Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism

Transplantation

Volumn 92, Issue 8, 2011, Pages 883-889

  Zitt, Emanuel ^a,b   Woess, Erich ^a   Mayer, Gert ^c   Lhotta, Karl ^a,b  

^a Academic Teaching Hospital Feldkirch   (Austria)

^b Vorarlberg Institute for Vascular Investigation and Treatment VIVIT   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Arterial blood pressure; Cinacalcet; Hyperparathyroidism; Kidney transplantation.; Magnesium

Indexed keywords

CALCIUM; CINACALCET; ELECTROLYTE; MAGNESIUM; PARATHYROID HORMONE; SODIUM;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; ELECTROLYTE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; MAGNESIUM URINE LEVEL; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BLOOD PRESSURE; CROSS-OVER STUDIES; ELECTROLYTES; FEMALE; HUMANS; HYPERPARATHYROIDISM; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NAPHTHALENES; PROSPECTIVE STUDIES; RECEPTORS, CALCIUM-SENSING;

EID: 80054754774     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31822d87e8     Document Type: Article

References (41)

1. Hebert SC. Extracellular calcium-sensing receptor: Implications for calcium and magnesium handling in the kidney. Kidney Int 1996; 50: 2129.
2. Vargas-Poussou R, Huang C, Hulin P, et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 2002; 13: 2259.
3. Nemeth EF, Steffey ME, Hammerland LG, et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 1998; 95: 4040.
4. Goodman WG, Frazao JM, Goodkin DA, et al. A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. Kidney Int 2000; 58: 436.
5. Urena P, Jacobson SH, Zitt E, et al. Cinacalcet and achievement of the NKF/K-DOQITM recommended target values for bone and mineral metabolism in real-world clinical practice-The ECHO observational study. Nephrol Dial Transplant 2009; 24: 2852.
6. Kruse AE, Eisenberger U, Frey FJ, et al. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1311.
7. Serra AL, Schwarz AA, Wick FH, et al. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1315.
8. Srinivas TR, Schold JD, Womer KL, et al. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J AmSoc Nephrol 2006; 1: 323.
9. Szwarc I, Argiles A, Garrigue V, et al. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 2006; 82: 675.
10. Rybczynska A, Boblewski K, Lehmann A, et al. Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats. Am J Hypertens 2005; 18: 364.
11. Odenwald T, Nakagawa K, Hadtstein C, et al. Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats. J Am Soc Nephrol 2006; 17: 655.
12. Iseki K, Massry SG, Campese VM. Effects of hypercalcemia and parathyroid hormone on blood pressure in normal and renal-failure rats. Am J Physiol 1986; 250: F924.
13. Fliser D, Franek E, Fode P, et al. Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant 1997; 12: 933.
14. Mann JF, Wiecek A, Bommer J, et al. Effects of parathyroidectomy on blood pressure in spontaneously hypertensive rats. Nephron 1987; 45: 46.
15. Ogata H, Ritz E, Odoni G, et al. Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. J Am Soc Nephrol 2003; 14: 959.
16. Diamond TW, Botha JR, Wing J, et al. Parathyroid hypertension. A reversible disorder. Arch Intern Med 1986; 146: 1709.
17. Niederle B, Roka R, Woloszczuk W, et al. Successful parathyroidectomy in primary hyperparathyroidism: A clinical follow-up study of 212 consecutive patients. Surgery 1987; 102: 903.
18. Evenepoel P, Claes K, Kuypers D, et al. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: A single centre study. Nephrol Dial Transplant 2005; 20: 1714.
19. Serra AL, Savoca R, Huber AR, et al. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant 2007; 22: 577.
20. Borchhardt KA, Heinzl H, Mayerwoger E, et al. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Transplantation 2008; 86: 919.
21. Riccardi D, Hall AE, Chattopadhyay N, et al. Localization of the extracellular Ca2/polyvalent cation-sensing protein in rat kidney. Am J Physiol 1998; 274: F611.
22. Riccardi D, Lee WS, Lee K, et al. Localization of the extracellular Ca(2)-sensing receptor and PTH/PTHrP receptor in rat kidney.AmJ Physiol 1996; 271: F951.
23. Hebert SC. Calcium and salinity sensing by the thick ascending limb: A journey from mammals to fish and back again. Kidney Int Suppl 2004: (91): S28.
24. Di Stefano A, Roinel N, de Rouffignac C, et al. Transepithelial Ca2 and Mg2 transport in the cortical thick ascending limb of Henle's loop of the mouse is a voltage-dependent process. Ren Physiol Biochem 1993; 16: 157.
25. de Jesus Ferreira MC, Helies-Toussaint C, Imbert-Teboul M, et al. Coexpression of a Ca2-inhibitable adenylyl cyclase and of a Ca2- sensing receptor in the cortical thick ascending limb cell of the rat kidney. Inhibition of hormone-dependent cAMP accumulation by extracellular Ca2. J Biol Chem 1998; 273: 15192.
26. Wang W, Lu M, Balazy M, et al. Phospholipase A2 is involved in mediating the effect of extracellular Ca2 on apical K channels in rat TAL. Am J Physiol 1997; 273: F421.
27. Amlal H, Wang Z, Soleimani M. Functional upregulation of Hα-ATPase by lethal acid stress in cultured inner medullary collecting duct cells. Am J Physiol 1997; 273: C1194.
28. Escalante B, Erlij D, Falck JR, et al. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 1991; 251: 799.
29. Bustamante M, Hasler U, Leroy V, et al. Calcium-sensing receptor attenuates AVP-induced aquaporin-2 expression via a calmodulindependent mechanism. J Am Soc Nephrol 2008; 19: 109.
30. Gesek FA, Friedman PA. On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells. J Clin Invest 1992; 90: 749.
31. de Groot T, Lee K, Langeslag M, et al. Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation. J Am Soc Nephrol 2009; 20: 1693.
32. Topala CN, Schoeber JP, Searchfield LE, et al. Activation of the Ca2- sensing receptor stimulates the activity of the epithelial Ca2 channel TRPV5. Cell Calcium 2009; 45: 331.
33. Sutton RA, Wong NL, Quamme GA, et al. Renal tubular calcium transport: Effects of changes in filtered calcium load. Am J Physiol 1983; 245: F515.
34. Bacic D, Lehir M, Biber J, et al. The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone. Kidney Int 2006; 69: 495.
35. Serra AL, Wuhrmann C, Wuthrich RP. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism. Am J Kidney Dis 2008; 52: 1151.
36. Serra AL, Braun SC, Starke A, et al. Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation. Am J Transplant 2008; 8: 803.
37. Peng LW, Logan JL, James SH, et al. Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient. Am J Med 2007; 120: E7.
38. Ziegelstein RC, Xiong Y, He C, et al. Expression of a functional extracellular calcium-sensing receptor in human aortic endothelial cells. Biochem Biophys Res Commun 2006; 342: 153.
39. Lewanczuk RZ, Resnick LM, Ho MS, et al. Clinical aspects of parathyroid hypertensive factor. J Hypertens Suppl 1994; 12: S11.
40. Rybczynska A, Lehmann A, Jurska-Jasko A, et al. Hypertensive effect of calcilytic NPS 2143 administration in rats. J Endocrinol 2006; 191: 189.
41. Carrasco FR, Perez-Flores I, Calvo N, et al. Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure. Transplant Proc 2009;41: 2385.